Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
OncoCyte Corp (OCX)
NASDAQ:OCX
OncoCyte (OCX) Stock Price & Analysis
400 Followers
OCX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.08 - $6.22
Previous Close$2.56
Volume38.16K
Average Volume (3M)54.69K
Market Cap
$21.18M
Enterprise Value$6.94M
Total Cash (Recent Filing)$14.24M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.1
Beta0.98
Next Earnings
May 14, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-23.74
Shares Outstanding8,273,073
10 Day Avg. Volume287,686
30 Day Avg. Volume54,689
Standard Deviation0.25
R-Squared0.03
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-1.19
Price to Sales (P/S)22.37
Price to Cash Flow (P/CF)-2.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-2.94
Enterprise Value/Gross Profit88.95
Enterprise Value/Ebitda7.98
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
OncoCyte News
PremiumCompany Announcements
OncoCyte Corp Announces Equity Placement and Fundraising Efforts
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OCX FAQ
What was OncoCyte Corp’s price range in the past 12 months?
OncoCyte Corp lowest stock price was $2.08 and its highest was $6.22 in the past 12 months.
What is OncoCyte Corp’s market cap?
Currently, no data Available
When is OncoCyte Corp’s upcoming earnings report date?
OncoCyte Corp’s upcoming earnings report date is May 14, 2024 which is in 25 days.
How were OncoCyte Corp’s earnings last quarter?
OncoCyte Corp released its earnings results on Apr 12, 2024. The company reported -$0.266 earnings per share for the quarter, beating the consensus estimate of -$0.655 by $0.389.
Is OncoCyte Corp overvalued?
According to Wall Street analysts OncoCyte Corp’s price is currently Overvalued.
Does OncoCyte Corp pay dividends?
OncoCyte Corp does not currently pay dividends.
What is OncoCyte Corp’s EPS estimate?
OncoCyte Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OncoCyte Corp have?
OncoCyte Corp has 8,273,073 shares outstanding.
What happened to OncoCyte Corp’s price movement after its last earnings report?
OncoCyte Corp reported an EPS of -$0.266 in its last earnings report, beating expectations of -$0.655. Following the earnings report the stock price went down -8.446%.
Which hedge fund is a major shareholder of OncoCyte Corp?
Among the largest hedge funds holding OncoCyte Corp’s share is Defender Capital, LLC.. It holds OncoCyte Corp’s shares valued at 179K.
---
OncoCyte Stock Smart Score
Company Description
OncoCyte Corp
OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.
---
OCX Earnings Call
Q4 2024
0:00 / 0:00
---
OCX Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering OCX
1 Year
1 Year Success Rate
0/17 ratings generated profit
1 Year Average Return
-70.30%
reiterated a buy rating 5 months ago
Copying Michael Matson's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -70.30% per trade.
---